Other names: ADT
Categories: Prescription Medication
Description:
Androgen Deprivation Therapy (ADT) is a cornerstone of treatment for high-risk prostate cancer and is almost always used in combination with radiation therapy. ADT works by lowering testosterone levels, which prostate cancer cells rely on to grow and survive.
In high-risk cases, ADT is typically given for a long duration—18 to 36 months—based on strong clinical evidence showing improved survival and reduced recurrence when combined with radiation. Common ADT agents include leuprolide, goserelin, degarelix, and relugolix. While effective, long-term ADT can cause side effects such as hot flashes, fatigue, sexual dysfunction, bone loss, and metabolic changes, so risks and benefits must be carefully considered.
Treatment For:
AI generated Summary: Based on the provided information, there are no reviews available for the effectiveness of Androgen Deprivation Therapy in treating High Risk Prostate Cancer. The author has not provided any review or rating for this treatment, making it difficult to assess its efficacy without further data.
The information, including but not limited to, text, graphics, images and other material contained on this website/app are for informational purposes only. No material on this site/app is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website/app.
Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.
